デフォルト表紙
市場調査レポート
商品コード
1159199

腱鞘炎治療の世界市場(2022年~2028年)

Tendonitis treatment Market 2022-2028

出版日: | 発行: Orion Market Research | ページ情報: 英文 150 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
腱鞘炎治療の世界市場(2022年~2028年)
出版日: 2022年09月22日
発行: Orion Market Research
ページ情報: 英文 150 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の腱鞘炎治療の市場規模は、予測期間中に2.6%のCAGRで成長すると予想されています。高齢化人口の増加、職業上の労働災害、身体活動や外傷による予期せぬ怪我に起因する腱炎の有病率の増加、ティーンエイジャーによる電子ガジェットの使用増加は、市場の成長を促進しています。

当レポートでは、世界の腱鞘炎治療市場について調査分析し、市場概要、競合情勢、市場分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向

第3章 競合情勢

  • 競合ダッシュボード
  • 主要戦略分析
  • 主要企業分析

第4章 市場決定要因

  • 促進要因
  • 抑制要因
  • 機会

第5章 市場セグメンテーション

  • 世界の腱炎治療市場:状態別
    • アキレス腱炎
    • 棘上筋腱炎
    • テニス肘
    • ゴルフ肘
    • 野球肘
  • 世界の腱炎治療市場:治療別
    • 外科的治療
    • 理学療法
    • 衝撃波療法
    • その他(温冷療法)

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • ASEAN諸国
    • 韓国
    • その他アジア太平洋
  • 世界のその他の地域

第7章 企業プロファイル

  • 3M Co
  • Abbott
  • Aksigen Hospital Care
  • Almatica Pharma, Inc.
  • AstraZeneca
  • Bayer AG
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • DJO Global, Inc.
  • GlaxoSmithKline PLC
  • Integra Life Sciences Corp
  • Merck and Co., Inc.
  • Ossur hf.
  • Pfizer
  • Replicel Life Sciences
  • Smith+Nephew
  • Stryker Corp
  • Teikoku Pharma USA, Inc
  • Teva Pharmaceuticals Industries
  • Tynor Orthotics Private Limited
  • Zimmer Biomet
図表

LIST OF TABLES

  • 1. GLOBAL TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
  • 2. GLOBAL TENDONITIS TREATMENT FOR ACHILLES TENDONITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL TENDONITIS TREATMENT FOR SUPRASPINATUS TENDONITIS MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
  • 4. GLOBAL TENDONITIS TREATMENT FOR TENNIS ELBOW MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
  • 5. GLOBAL TENDONITIS TREATMENT FOR GOLFER'S ELBOW MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
  • 6. GLOBAL TENDONITIS TREATMENT FOR PITCHER'S ELBOW MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
  • 7. GLOBAL TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
  • 8. GLOBAL SURGICAL TREATMENT IN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL PHYSICAL THERAPY IN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL SHOCKWAVE THERAPY IN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL TENDONITIS TREATMENT MARKET FOR OTHER TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 13. NORTH AMERICAN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 14. NORTH AMERICAN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
  • 15. NORTH AMERICAN MAGNESIUM ALLOYSMARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
  • 16. EUROPEAN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 17. EUROPEAN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
  • 18. EUROPEAN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
  • 19. ASIA-PACIFIC TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 20. ASIA-PACIFIC TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
  • 21. ASIA-PACIFIC TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
  • 22. REST OF THE WORLD TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
  • 23. REST OF THE WORLD TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)

LIST OF FIGURES

1. IMPACT OF COVID-19 ON GLOBAL TENDONITIS TREATMENT MARKETMARKET, 2021-2028 (% MILLION)

2. IMPACT OF COVID-19 ON GLOBAL TENDONITIS TREATMENT MARKETMARKET BY SEGMENT, 2021-2028 (% MILLION)

  • 3. RECOVERY OF TENDONITIS TREATMENT MARKETMARKET, 2021-2028 (%)
  • 4. GLOBAL TENDONITIS TREATMENT MARKET SHARE BY CONDITION, 2021 VS 2028 (%)
  • 5. GLOBAL TENDONITIS TREATMENT MARKET SHARE BY TREATMENT, 2021 VS 2028 (%)
  • 6. GLOBAL TENDONITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL TENDONITIS TREATMENT FOR ACHILLES TENDONITIS MARKET SIZE, 2021-2028 ($ MILLION)
  • 8. GLOBAL TENDONITIS TREATMENT FOR SUPRASPINATUS TENDONITIS MARKET SIZE, 2021-2028 ($ MILLION)
  • 9. GLOBAL TENDONITIS TREATMENT FOR TENNIS ELBOW MARKET SIZE, 2021-2028 ($ MILLION)
  • 10. GLOBAL TENDONITIS TREATMENT FOR GOLFER'S ELBOW MARKET SIZE, 2021-2028 ($ MILLION)
  • 11. GLOBAL TENDONITIS TREATMENT FOR PITCHER'S ELBOW MARKET SIZE, 2021-2028 ($ MILLION)
  • 12. GLOBAL SURGICAL TREATMENT IN TENDONITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL PHYSICAL THERAPY IN TENDONITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL SHOCKWAVE THERAPY IN TENDONITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. GLOBAL TENDONITIS TREATMENT FOR OTHER TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 16. US TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. CANADA TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. UK TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. FRANCE TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. GERMANY TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. ITALY TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. SPAIN TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. ROE TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. INDIA TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. CHINA TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. JAPAN TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. ASEAN TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. SOUTH KOREA TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. REST OF ASIA-PACIFIC TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. REST OF THE WORLD TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
目次
Product Code: OMR2026165

Global Tendonitis Treatment Market Size, Share & Trends Analysis Report by Condition (Achilles Tendonitis, Supraspinatus Tendonitis, Tennis Elbow, Golfer's Elbow, and Pitcher's Elbow), By Treatment (Surgical Treatment, Physical therapy, Shockwave Therapy, and Others), Forecast Period 2022-2028

The global market for tendonitis treatment is projected to have a considerable CAGR of around 2.6% during the forecast period. Treatment for tendonitis aims to alleviate pain and reduce inflammation. Increasing prevalence of tendonitis due to growth in the aging population, sports, and occupational work injuries, and unexpected injuries induced by physical activity and trauma are expected to drive market growth over the forecast period. Furthermore, the increased use of electronic gadgets among children and teenagers makes them more sensitive to problems with their hands, arms, and wrists, increasing their chances of getting tendinitis. Additionally, increasing career opportunities and a growing desire for good fitness have boosted the number of people who choose sports as a career or a hobby. As a result, their chances of getting injured are projected to increase which in turn will fuel the treatment demand. However, a lack of public understanding of the condition and its advanced treatments may have a negative impact on the market.

The global tendonitis treatment market is segmented based on the condition and treatment. Based on the condition, the market is segmented into Achilles tendonitis, supraspinatus tendonitis, tennis elbow, golfer's elbow, and pitcher's elbow. Based on the treatment the market is further categorized as surgical treatment, physical therapy, shockwave therapy, and others.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia-Pacific is estimated to have the largest market share in the global tendinitis treatment market and the factors that are attributing the growth are the growing number of tendonitis surgeries performed in the region and rising disposable income. Furthermore, the other key factors driving the market are ongoing research in this field, increasing products in the pipeline for tendonitis treatment, particularly in China and Japan.

The key players of the market include DJO Global Inc., Zimmer Biomet, 3M Co, and AKSIGEN, among others. These market players adopt various strategies such as product launches, partnerships, collaborations, mergers, and acquisitions to sustain a strong position in the market. In September 2021, Ossur, a global innovator in prosthetic and non-invasive orthopedic technologies launched the new Rebound Post-Op Elbow Brace, a non-invasive, lightweight adjustable brace, that is designed to be the lightest weight in the market and provides both elbow immobilization and range-of-motion restriction for the patients who may have experienced a variety of conditions such as chronic elbow injuries and tennis elbow release.

Research Methodology

The market study of the global tendinitis treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global tendinitis treatment Research and Analysis by Condition

2. Global tendinitis treatment Research and Analysis by Treatment

The Report Covers:

  • Comprehensive Research Methodology of the global tendinitis treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global tendinitis treatment market.
  • Insights about market determinants that are stimulating the global tendinitis treatment market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Tendonitis Treatment Industry
  • Recovery Scenario of Global Tendonitis Treatment Industry
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Competitive Dashboard
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Tendonitis Treatment Market by Condition
    • 5.1.1. Achilles Tendonitis
    • 5.1.2. Supraspinatus Tendonitis
    • 5.1.3. Tennis Elbow
    • 5.1.4. Golfer's Elbow
    • 5.1.5. Pitcher's Elbow
  • 5.2. Global Tendonitis Treatment Market by Treatment
    • 5.2.1. Surgical Treatment
    • 5.2.2. Physical therapy
    • 5.2.3. Shockwave Therapy
    • 5.2.4. Others (Hot and Cold Therapy)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. ASEAN
    • 6.3.5. South Korea
    • 6.3.6. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. 3M Co
  • 7.2. Abbott
  • 7.3. Aksigen Hospital Care
  • 7.4. Almatica Pharma, Inc.
  • 7.5. AstraZeneca
  • 7.6. Bayer AG
  • 7.7. Boehringer Ingelheim Pharmaceuticals, Inc.
  • 7.8. DJO Global, Inc.
  • 7.9. GlaxoSmithKline PLC
  • 7.10. Integra Life Sciences Corp
  • 7.11. Merck and Co., Inc.
  • 7.12. Ossur hf.
  • 7.13. Pfizer
  • 7.14. Replicel Life Sciences
  • 7.15. Smith+Nephew
  • 7.16. Stryker Corp
  • 7.17. Teikoku Pharma USA, Inc
  • 7.18. Teva Pharmaceuticals Industries
  • 7.19. Tynor Orthotics Private Limited
  • 7.20. Zimmer Biomet